In addition, we observed the upregulation of several other phosphosites in the post-treatment tumor of Patient 4, such as PAK4 (S474) and STAT5B (Y699), potentially associated with bypass mechanisms for acquired resistance42,43. The gene discussed is STAT5B; the disease is neoplasm.